Cargando…

Clinical trial recommendations for potential Alport syndrome therapies

Alport syndrome is experiencing a remarkable increase in preclinical investigations. To proactively address the needs of the Alport syndrome community, as well as offer clarity for future clinical research sponsors, the Alport Syndrome Foundation hosted a workshop to generate consensus recommendatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weinstock, B. André, Feldman, David L., Fornoni, Alessia, Gross, Oliver, Kashtan, Clifford E., Lagas, Sharon, Lennon, Rachel, Miner, Jeffrey H., Rheault, Michelle N., Simon, James F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7614298/ https://www.ncbi.nlm.nih.gov/pubmed/32386680 http://dx.doi.org/10.1016/j.kint.2020.02.029

Ejemplares similares

The importance of clinician, patient and researcher collaborations in Alport syndrome
por: Rheault, Michelle N., et al.
Publicado: (2019)

Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative
por: Kashtan, Clifford E., et al.
Publicado: (2012)

The 2014 International Workshop on Alport Syndrome
por: Miner, Jeffrey H, et al.
Publicado: (2014)

Alport syndrome: facts and opinions
por: Kashtan, Clifford
Publicado: (2017)

Advances and unmet needs in genetic, basic and clinical science in Alport syndrome: report from the 2015 International Workshop on Alport Syndrome
por: Gross, Oliver, et al.
Publicado: (2017)

Multidisciplinary Management of Alport Syndrome: Current Perspectives
por: Kashtan, Clifford
Publicado: (2021)

Women and Alport syndrome
por: Rheault, Michelle N.
Publicado: (2011)

Novel Therapies for Alport Syndrome
por: Chavez, Efren, et al.
Publicado: (2022)

Renal transplantation in patients with Alport syndrome: patient selection, outcomes, and donor evaluation
por: Kashtan, Clifford E
Publicado: (2018)

Targeting Fibrosis Pathways in Alport Syndrome—Is it Too Late?
por: Rheault, Michelle N.
Publicado: (2023)

The 2019 and 2021 International Workshops on Alport Syndrome
por: Daga, Sergio, et al.
Publicado: (2022)

Urinary Monocyte Chemoattractant Protein-1 in Patients With Alport Syndrome
por: Kashtan, Clifford, et al.
Publicado: (2022)

Somatic Mosaicism in a Male Patient With X-linked Alport Syndrome
por: Bu, Lihong, et al.
Publicado: (2019)

Angiotensin converting enzyme inhibitor therapy in children with Alport syndrome: effect on urinary albumin, TGF-β, and nitrite excretion
por: Adler, Liora, et al.
Publicado: (2002)

Empagliflozin reduces podocyte lipotoxicity in experimental Alport syndrome
por: Ge, Mengyuan, et al.
Publicado: (2023)

Pathology versus molecular genetics: (re)defining the spectrum of Alport syndrome
por: Miner, Jeffrey H.
Publicado: (2014)

Characterization of Sensorineural Hearing Loss in Children with Alport Syndrome
por: Boeckhaus, Jan, et al.
Publicado: (2020)

Editorial: Collagen IV nephropathies: Alport syndrome and beyond
por: Borza, Dorin-Bogdan, et al.
Publicado: (2022)

Discoidin domain receptor 1 activation links extracellular matrix to podocyte lipotoxicity in Alport syndrome
por: Kim, Jin-Ju, et al.
Publicado: (2020)

Alport Syndrome With Kidney Cysts Is Still Alport Syndrome
por: Savige, Judy, et al.
Publicado: (2021)

Metformin ameliorates the severity of experimental Alport syndrome
por: Omachi, Kohei, et al.
Publicado: (2021)

The Contribution of COL4A5 Splicing Variants to the Pathogenesis of X-Linked Alport Syndrome
por: Yamamura, Tomohiko, et al.
Publicado: (2022)

Alport's Syndrome in Pregnancy
por: Mehta, Suchita, et al.
Publicado: (2013)

Alport Syndrome: From Pathogenesis to a Potential Therapy
Publicado: (2006)

Safety and Efficacy of the ACE-Inhibitor Ramipril in Alport Syndrome: The Double-Blind, Randomized, Placebo-Controlled, Multicenter Phase III EARLY PRO-TECT Alport Trial in Pediatric Patients
por: Gross, Oliver, et al.
Publicado: (2012)

Organoprotective Effects of Spironolactone on Top of Ramipril Therapy in a Mouse Model for Alport Syndrome
por: Rubel, Diana, et al.
Publicado: (2021)

Genetic diagnosis of Alport syndrome
por: Cheong, Hae Il
Publicado: (2019)

Alport Syndrome Classification and Management
por: Warady, Bradley A., et al.
Publicado: (2020)

Auditory Perception in Alport’s Syndrome
por: Viveiros, Carla Mherlyn, et al.
Publicado: (2015)

Podocyte Depletion in Thin GBM and Alport Syndrome
por: Wickman, Larysa, et al.
Publicado: (2016)

Ultrastructural Characterization of the Glomerulopathy in Alport Mice by Helium Ion Scanning Microscopy (HIM)
por: Tsuji, Kenji, et al.
Publicado: (2017)

Genotype–phenotype correlations and nephroprotective effects of RAAS inhibition in patients with autosomal recessive Alport syndrome
por: Zhang, Yanqin, et al.
Publicado: (2021)

Anterior lenticonus associated with Alport syndrome
por: Jinagal, Jitender, et al.
Publicado: (2018)

Pulmonary calcinosis associated with Alport syndrome
por: Mismetti, Valentine, et al.
Publicado: (2022)

Alport Syndrome: A Comprehensive Review
por: Adone, Avanti, et al.
Publicado: (2023)

Ocular Manifestations and Potential Treatments of Alport Syndrome: A Systematic Review
por: Ramakrishnan, Rahul, et al.
Publicado: (2022)

Potential Renal Damage Biomarkers in Alport Syndrome—A Review of the Literature
por: Gomes, Ana Marta, et al.
Publicado: (2022)

Molecular testing for adult type Alport syndrome
por: Pont-Kingdon, Genevieve, et al.
Publicado: (2009)

It is an Alport syndrome, not a simple hypertensive retinopathy
por: Gadde, Aruna Kumari, et al.
Publicado: (2018)

Glomerular endothelial cell heterogeneity in Alport syndrome
por: Soloyan, Hasmik, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g6vjnpccvjgvo47pcs1t0qjvv0